12 July 2018

Statins (lipid-lowering drugs) are among the most widely prescribed medications, because they markedly reduce the incidence of major cardiovascular events by lowering LDL-cholesterol. However, muscle symptoms such as fatigue, myalgia, cramps, stiffness and tenderness are expected to occur in 15-20% of statin users, which may lead to nonadherence to statin treatment. Multiple studies show that statins are linked to mitochondrial disturbances, which may be the cause of the muscle symptoms.

This year the research during the Four Days Marches of Maria Hopman and her team, which takes place for the 12th year now,  focuses on statin users who walk the Nijmegen marches. The Four Days Marches are an unique setting to examine the effects of intense exercise on muscle functioning. One hundred participants are included in this study to gain more insight into the influence of statins on muscle performance. Statin users with muscle complaints will be compared to statin users without complaints and non-statin users. Prior and during the Four Days Marches extensive measurements are performed to assess muscle function, muscle damage, mitochondrial function, pain and fatigue.

More information:  www.vierdaagseonderzoek.nl

Maria Hopman is member of research theme Mitochondrial diseases.

Related news items


Research Integrity Round: The ConScience App 15 February 2019

14 February 2019

To introduce the new Netherlands Code of Conduct for Research Integrity we invited ‘Het Acteursgenootschap’ to perform ‘The ConScience App’, a theatre piece designed to move the debate on scientific knowledge. All Radboudumc researchers are invited to attend this event.

read more

Prevalence of sexual harassment in academic medicine

7 February 2019

In JAMA Internal Medicine Sabine Oertelt-Prigione described how sexual harassment is a pervasive phenomenon that can affect anyone in the workplace.

read more

Radiotherapy-associated angiosarcoma after breast cancer treatment

7 February 2019

In Jama Oncology Anouk Rombouts and co-workers showed that one in 1000 patients who were treated with radiotherapy for breast cancer will develop an angiosarcoma of the breast.

read more

Optimizing high-dose rifampicin against tuberculosis

7 February 2019

In the American Journal of Respiratory and Critical Care Medicine Lindsey te Brake and colleagues described the shortcomings of a moderate increase in rifampicin dosing.

read more

Determinants for variation in Integrated Head and Neck Cancer

7 February 2019

In National Comprehensive Cancer Network Lydia van Overveld and Rosella Hermens described the quality of current integrated head and neck cancer care using evidence-based quality indicators, the variation between Dutch hospitals, and the influence of patient and hospital characteristics.

read more

Poster Award for Florieke Eggermont et al.

7 February 2019

At the 7th Dutch conference on Bio-Medical Engineering on 24 and 25 January 2019, the award for best poster presentation was received by Florieke Eggermont, Yvette van der Linden, Loes Derikx, Marianne de Jong, An Snyers, Tom Rozema, Nico Verdonschot and Esther Tanck.

read more